11.200
+2,75%
2026-10-19
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +162.5% | +191.8% | 3 / 3 | -11.6% | +5.79 pp | +2.19 pp | +5.5% | 0.72 | 12.29 | 514 | −11,6% | 17,0 | +162,5% | 12.29 | 18.22 | −32,5% |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 11.200 (close price on 2026-10-19)EPS (TTM): 911,0
Financial charts
1.Revenue & growth
VND bn514Q2/26
1.Revenue & growth
VND bn514Q2/26
2.Profit & growth
VND bn11,6Q2/26
3.Profit mix (Penman)
VND bn44,9Q2/26
4.Margins & cost structure
%14.4%Q2/26
5.Returns & cash cycle
% · days4.8%Q2/26
6.Earnings quality & cash
VND bn297Q2/26
7.Asset structure
VND bn1.634Q2/26
8.Funding & debt health
VND bn · times1.634Q2/26
9.Revenue backlog
VND bn27,5Q2/26
10.Valuation
times · %13,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %232Q2/26
Adjusted EPS growth, latest quarter
79.6%
Average adjusted EPS growth, 3 quarters
164%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26